Dr. Yoav Golan, MD

Dr. Golan practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Golan's NPI, 1487760203, was assigned on August 22, 2006. Dr. Golan graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1990. Dr. Golan holds Massachusetts license 210052.

Dr. Golan's primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Golan's primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. The medical group on file is Mass General Brigham Medical Group. Dmand AI also links Dr. Golan to 2 more medical groups and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Golan practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Golan's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Golan is licensed in Massachusetts.

CMS data shows 269 Medicare services from Dr. Golan across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $26,204 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Golan in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Golan's median patient age at 57, with 40% women.

In 2024, Dr. Golan wrote 8,158 Medicare Part D claims for 6,558 patients. 0% of them were for generic drugs. CMS names the drug for 8,102 of them, across 6 drugs with 11 or more claims each, at $1,876,052 in total drug cost. In 2023, CMS named 9,748 claims across 5 drugs.

Dr. Golan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 41 papers to Dr. Golan, published from 2003 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Clostridium Infections and Clostridioides difficile. Dr. Golan has published most often in Clin Infect Dis. Dr. Golan's most frequent co-authors are David R. Snydman, MD, Herbert Lancashire Dupont, MD and Kathleen M. Mullane.

Dmand AI links Dr. Golan to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Clostridium Infections, COVID-19 and Gram-Positive Bacterial Infections.

CMS Open Payments shows 2,287 general payments to Dr. Golan from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Allergan Inc. paid the most, $680,208.

Dmand AI lists 1 award for Dr. Golan, most recently CMS Stage 1 EHR in 2013.

Dr. Golan graduated from The Hebrew University of Jerusalem Hadassah Medical School in 1990.

Dr. Golan is in network with 6 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.